Researchers from The Institute of Cancer Research in London have developed a new test that can predict colorectal cancer risk ...
Doctors believe new test could lead to earlier diagnoses and more effective treatment for thousands of patients ...
Although there are several existing hospital-based registries, including the one at the National Institute of Cancer Research and Hospital (NICRH), Bangladesh lacks a centralised or national ...
Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...
To identify people's cancer risk, scientists at the Institute of Cancer Research (ICR), working with doctors at St Mark's in London, the UK's specialist bowel hospital, found that people with IBD ...
IIT Madras launches cancer genome database to transform cancer research in India, aiming to identify biomarkers and ...
Professor Kristian Helin, chief executive at the Institute of Cancer Research, London, said, "Drug resistance is one of the biggest problems we face in treating cancer. Finding drugs that can slow ...
Director General of the National Institute for Cancer Research and Treatment, Dr. Usman Malami Aliyu, who was a guest on Channels Television’s breakfast show, … Continue reading FG To Provide Free Can ...
Scientists from The Institute of Cancer Research, London, showed that the drug, NXP800, discovered at the same institute, slowed the growth of prostate cancer cells, including in cancer cells that are ...
Michael S. Gordon, M.D., Chief Medical Officer of HonorHealth Research Institute, today was named a Fellow of the American Society of Clinical Oncology (FASCO), the world’s leading professional ...
The Institute of Cancer Research (the ICR) is a cancer research university located in London, United Kingdom and a constituent college of the federal University of London. It was founded in 1909 ...
Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 was ...